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Highly active anti-retroviral therapy (HAART) effects sus-
tained suppression of viral replication in infected indivi-
duals. Despite this, viral replication rapidly resumes if
therapy is interrupted. The prevailing view is that viral
persistence during HAART is sustained by a reservoir of
latently infected, quiescent CD4+ T-lymphocytes, a view
that is supported by the apparent lack of viral evolution in
the resting CD4+ T cell reservoir and the apparent lack of
change in low level plasma viremia when therapy is inten-
sified. A less popular view is that viral persistence in
HAART may be sustained by a low level of ongoing or
“cryptic” replication, a view that is supported in part by
our recent work measuring unintegrated cDNA and speci-
fically episomal cDNA in HAART- treated patients.
In order to characterize the reservoirs that persist in the
face of HAART, we have been examining the dynamics of
HIV-1 in tissue viral reservoirs and the virologic response
to therapy in lymphoid tissue. Lymphoid tissue was
obtained from patients at various intervals after HAART
initiation and the virologic response as well as intracellular
drug levels in cells from lymphoid tissue was examined.
Our analysis indicates that suppressive therapy is limited
in its ability to curtail HIV-1 replication in lymphoid tissue
and that this may be a consequence of poor intracellular
sequestration of some antiretrovirals in cells of lymphoid
tissue. These results have implications for strategies aimed
at limiting viral persistence in the face of HAART.
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